Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Analysis based on BRAF mutation status revealed a more pronounced therapeutic advantage of mRNA-4157 combined with pembrolizumab in BRAF-mutant patients (HR 0.332) relative to wild-type patients (HR 0.808)
Which medication is right for me
The Methylation Profile Plasma test is particularly useful for patients with chronic health conditions that do not respond to conventional treatments, as it provides a more comprehensive picture of their underlying health status
The unmodified cysteine residue for the ATR-107 peptide is also predicted to reside at P3 and be TCR-facing when bound by HLA-DRB1*07:01
The relative phosphorylation activities of Cp1B towards each substrate were derived by the consumption of NADH at the time point where each reaction mixture was incubated at 30 C for 30 min
US$ 28.42
US$ 28.80
US$ 24.85
US$ 28.65
US$ 20.72
US$ 25.05
